Effects of Large Extracellular Vesicles from Kidney Cancer Patients on the Growth and Environment of Renal Cell Carcinoma Xenografts in a Mouse Model

被引:0
|
作者
Ferragu, Matthieu [1 ]
Vergori, Luisa [2 ]
Le Corre, Vincent [1 ]
Bellal, Sarah [3 ]
Martinez, Maria del Carmen [2 ,4 ]
Bigot, Pierre [1 ]
机构
[1] Angers Univ Hosp, Urol Dept, F-49100 Angers, France
[2] INSERM, UMR 1063, Stress Oxydant & Pathol Metab, F-49100 Angers, France
[3] Angers Univ Hosp, Anatomopathol Dept, F-49100 Angers, France
[4] Univ Montpellier, PhyMedExp, INSERM, CNRS,UMR, F-34090 Montpellier, France
关键词
cancer; renal cancer; large extracellular vesicle; tumor growth; angiogenesis; peritumoral environment; xenograft; mouse model; EXOSOMES; ANGIOGENESIS; ESTABLISHMENT; MECHANISMS; PHENOTYPE; DIAGNOSIS; SURVIVAL;
D O I
10.3390/cimb45030163
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plasma membrane-derived vesicles, also referred to as large extracellular vesicles (lEVs), are implicated in several pathophysiological situations, including cancer. However, to date, no studies have evaluated the effects of lEVs isolated from patients with renal cancer on the development of their tumors. In this study, we investigated the effects of three types of lEVs on the growth and peritumoral environment of xenograft clear cell renal cell carcinoma in a mouse model. Xenograft cancer cells were derived from patients' nephrectomy specimens. Three types of lEVs were obtained from pre-nephrectomy patient blood (cEV), the supernatant of primary cancer cell culture (sEV) and from blood from individuals with no medical history of cancer (iEV). Xenograft volume was measured after nine weeks of growth. Xenografts were then removed, and the expression of CD31 and Ki67 were evaluated. We also measured the expression of MMP2 and Ca9 in the native mouse kidney. lEVs from kidney cancer patients (cEV and sEV) tend to increase the size of xenografts, a factor that is related to an increase in vascularization and tumor cell proliferation. cEV also altered organs that were distant from the xenograft. These results suggest that lEVs in cancer patients are involved in both tumor growth and cancer progression.
引用
收藏
页码:2491 / 2504
页数:14
相关论文
共 50 条
  • [31] Dynamic prognostic model for kidney renal clear cell carcinoma (KIRC) patients by combining clinical and genetic information
    Zhao, Huiling
    Cao, Yuting
    Wang, Yue
    Zhang, Liya
    Chen, Chen
    Wang, Yaoyan
    Lu, Xiaofan
    Liu, Shengjie
    Yan, Fangrong
    SCIENTIFIC REPORTS, 2018, 8
  • [32] Prognostic Impact of Cytoreductive Nephrectomy in Patients with Metastatic Renal Cell Carcinoma: Data from a Large Population-Based Database
    Alnimer, Yanal
    Qasrawi, Ayman
    Yan, Donglin
    Wang, Peng
    UROLOGY JOURNAL, 2022, 19 (02) : 111 - 119
  • [33] Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis
    Procopio, G.
    Bellmunt, J.
    Dutcher, J.
    Bracarda, S.
    Knox, J.
    Brueckner, A.
    Molnar, I.
    Escudier, B.
    Hutson, T. E.
    BRITISH JOURNAL OF CANCER, 2013, 108 (02) : 311 - 318
  • [34] Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: Results from a large patient cohort
    Iacovelli, Roberto
    Carteni, Giacomo
    Sternberg, Cora N.
    Milella, Michele
    Santoni, Matteo
    Di Lorenzo, Giuseppe
    Ortega, Cinzia
    Sabbatini, Roberto
    Ricotta, Riccardo
    Messina, Caterina
    Lorusso, Vito
    Atzori, Francesco
    De Vincenzo, Fabio
    Sacco, Cosimo
    Boccardo, Francesco
    Valduga, Francesco
    Massari, Francesco
    Baldazzi, Valentina
    Cinieri, Saverio
    Mosca, Alessandra
    Ruggeri, Enzo Maria
    Berruti, Alfredo
    Cerbone, Linda
    Procopio, Giuseppe
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (09) : 2134 - 2142
  • [35] Religious Coping in Cancer: A Quantitative Analysis of Expressive Writing Samples From Patients With Renal Cell Carcinoma
    Narayanan, Santhosshi
    Milbury, Kathrin
    Wagner, Richard
    Cohen, Lorenzo
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2020, 60 (04) : 737 - +
  • [36] Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients
    Liontos, Michalis
    Trigka, Eleni-Andriana
    Korkolopoulou, Penelope
    Tzannis, Kimon
    Lainakis, Giorgos
    Koutsoukos, Konstantinos
    Kostouros, Efthymios
    Lykka, Maria
    Papandreou, Christos N.
    Karavasilis, Vassilis
    Christodoulou, Christos
    Papatsoris, Athanasios
    Skolarikos, Andreas
    Varkarakis, Ioannis
    Adamakis, Ioannis
    Alamanis, Christos
    Stravodimos, Konstantinos
    Mitropoulos, Dionysios
    Deliveliotis, Charalambos
    Constantinidis, Constantinos A.
    Saetta, Angelica
    Patsouris, Efstratios
    Dimopoulos, Meletios I.
    Bamias, Aristotelis
    WORLD JOURNAL OF UROLOGY, 2017, 35 (03) : 411 - 419
  • [37] The impact of kidney function on the outcome of metastatic renal cell carcinoma patients treated with vascular endothelial growth factor-targeted therapy
    Macfarlane, Robyn
    Heng, Daniel Y. C.
    Xie, Wanling
    Knox, Jennifer J.
    McDermott, David F.
    Rini, Brian I.
    Kollmannsberger, Christian
    Choueiri, Toni K.
    CANCER, 2012, 118 (02) : 365 - 370
  • [38] Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma
    Mason, Ross J.
    Wood, Lori
    Kapoor, Anil
    Basappa, Naveen
    Bjarnason, George
    Boorjian, Stephen A.
    Breau, Rodney H.
    Cagiannos, Ilias
    Jewett, Michael
    Karakiewicz, Pierre, I
    Kassouf, Wassim
    Kollmannsberger, Christian
    Lalani, Aly-Khan A.
    Lattouf, Jean-Baptiste
    Lavallee, Luke T.
    Pautler, Stephen
    Power, Nicholas
    Richard, Patrick
    So, Alan
    Tanguay, Simon
    Rendon, Ricardo A.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2019, 13 (06): : 166 - 174
  • [39] Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database
    Park, Jae Young
    Tae, Bum Sik
    Jeong, Chorok Wook
    Song, Cheryn
    Seo, Seong Il
    Hong, Sung Kyu
    Chung, Jinsoo
    Hong, Sang-Hoo
    Hwang, Eu Chang
    Kwak, Cheol
    Seo, Ill Young
    Park, Suyeon
    Park, Chanwang
    INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (03) : 260 - 268
  • [40] Extracellular Vesicles Enriched in hsa-miR-301a-3p and hsa-miR-1293 Dynamics in Clear Cell Renal Cell Carcinoma Patients: Potential Biomarkers of Metastatic Disease
    Dias, Francisca
    Teixeira, Ana Luisa
    Nogueira, Ines
    Morais, Mariana
    Maia, Joana
    Bodo, Cristian
    Ferreira, Marta
    Silva, Alexandra
    Vilhena, Manuela
    Lobo, Joao
    Sequeira, Jose Pedro
    Mauricio, Joaquina
    Oliveira, Jorge
    Kok, Klaas
    Costa-Silva, Bruno
    Medeiros, Rui
    CANCERS, 2020, 12 (06)